Products

ResumeAI

AI-native

Craft an ATS-Proof Resume That Gets Interviews

airesume.info HR & Careers / Job Search & Resumes

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$9.99/mo
Lower than 53% of peersNiche median $10/mo
Creators
Unlinked
No verified creators
Launched
4mo ago
2026-07-21 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI resume builder that beats the ATS

    Jul 21 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-06-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
$0
3 templates, full editor, PDF export, hosted link & view analytics.
Premium templates
$9.99/once
custom colors & fonts · template perks

Trial: None · 1 paid tier ($9.99) · Observed 2026-11-06 · Pricing page

Entry price $9.99/mo, Lower than 53% of peers; “Job Search & Resumes” median is $10/mo.View pricing benchmark

Website snapshots

Indexed 2026-07-21

Key pages

Desktop & mobile archive
airesume.info/ Snapshot 2026-11-06

Questions & evidence

How much does ResumeAI cost?
Free: $0; Premium templates: $9.99/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ResumeAI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ResumeAI and what platforms does it support?
ResumeAI is catalogued under Job Search & Resumes: Craft an ATS-Proof Resume That Gets Interviews. Supported platforms: Web.

Related products in this category

HR & Careers / Job Search & Resumes

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.